FB2024_03 , released June 25, 2024
Allele: Dmel\MetW3
Open Close
General Information
Symbol
Dmel\MetW3
Species
D. melanogaster
Name
FlyBase ID
FBal0191692
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Key Links
Genomic Maps

Allele class
Mutagen
Nature of the Allele
Allele class
Progenitor genotype
Cytology
Description

Amino acid replacement: E5G.

Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Nucleotide change:

A11616881G

Amino acid change:

E5G | Met-PA; E5G | Met-PB

Reported amino acid change:

E5G

Comment:

Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.

Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 0 )
Disease
Evidence
References
Modifiers Based on Experimental Evidence ( 0 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

Mutants have defective facets in the posterior part of the eye.

In addition to delayed larval development, the body weight of animals expressing MetScer\UAS.cBa driven by Scer\GAL4Adh.PF in a hemizygous MetW3 mutant background is dramatically reduced in comparison to Scer\GAL4Adh.PF controls. Once these mutants reach wandering third instar larval stage, their fat body cells begin to dissociate and undergo dramatic apoptosis.

Homozygotes show increased resistance to methoprene compared to controls.

Homozygous females have a reduced rate of oviposition compared to controls.

78% of mutant flies have a small number of defective ommatidia in the posterior quarter of the eye.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Enhanced by
Statement
Reference

MetW3 has visible phenotype, enhanceable by brrbp-2

Suppressed by
Statement
Reference
NOT suppressed by
Statement
Reference

MetW3 has visible phenotype, non-suppressible by gceUAS.cBa/Scer\GAL4Lsp2.PH

Other
Phenotype Manifest In
Enhanced by
Statement
Reference

MetW3 has eye phenotype, enhanceable by brrbp-2

Suppressed by
Statement
Reference
NOT suppressed by
Statement
Reference
Enhancer of
Statement
Reference

MetW3/MetW3 is an enhancer of ovary phenotype of br1

Additional Comments
Genetic Interactions
Statement
Reference

The defective facet phenotype seen in MetW3 flies is suppressed by expression of gceScer\UAS.cBa under the control of either Scer\GAL4tub.PU or Scer\GAL4dan-AC116, but is not suppressed by expression of gceScer\UAS.cBa under the control of Scer\GAL4Lsp2.PH.

Expression of gcedsRNA.Scer\UAS.cBa under the control of Scer\GAL4Act5C.PI enhances the defective facet phenotype seen in MetW3 flies.

br1, Rst(1)JHW3 double mutant escapers show significantly reduced levels of oogenesis compared to br1 single mutants.

The expressivity of the defective eye phenotype seen in MetW3 flies is increased by brrbp-2 but not by br1.

Xenogenetic Interactions
Statement
Reference
Complementation and Rescue Data
Comments

Either of the transgenic lines Meths.PA or P{UAS-Met.B}pV2 can rescue the MetW3 mutant eye phenotype due to their Scer\GAL4-independent expression of MetScer\UAS.cBa. The methoprene resistance of MetW3 mutants is also lost as a result of MetScer\UAS.cBa expression.

Scer\GAL4Act-driven MetScer\UAS.cBa rescues the MetW3 mutant eye phenotype.

Images (0)
Mutant
Wild-type
Stocks (2)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (3)
Reported As
Name Synonyms
Secondary FlyBase IDs
    References (5)